Cargando…
The pharmacotherapy preferred by doctors in treatment of patients diagnosed with asthma or chronic obstructive pulmonary disease or allergic rhinitis and concomitant diseases: an epidemiological analysis
INTRODUCTION: The clinical course of asthma and chronic obstructive pulmonary disease (COPD) is influenced by the co-occurrence of other chronic diseases and their pharmacotherapy. There are no data associated with the doctors’ pharmacotherapy preferences in treatment of patients with asthma, COPD o...
Autores principales: | Nowak, Marcin, Brożek, Grzegorz, Doniec, Zbigniew, Olszanecka-Glinianowicz, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420608/ https://www.ncbi.nlm.nih.gov/pubmed/28507495 http://dx.doi.org/10.5114/ada.2017.67081 |
Ejemplares similares
-
Topical pharmacotherapy for allergic rhinitis: Nedocromil
por: Mabry, Richard L.
Publicado: (1993) -
Therapeutic preferences and factors determining the use of inhaled corticosteroids with long-acting β(2)-agonists in patients with asthma and chronic obstructive pulmonary disease
por: Olszanecka-Glinianowicz, Magdalena, et al.
Publicado: (2020) -
The adherence and illness perception of patients diagnosed with asthma or chronic obstructive pulmonary disease treated with polytherapy using new generation Cyclohaler
por: Olszanecka-Glinianowicz, Magdalena, et al.
Publicado: (2014) -
Mechanisims of asthma and allergic disease – 1066. Ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2013) -
KAAACI Allergic Rhinitis Guidelines: Part 1. Update in Pharmacotherapy
por: Yang, Song-I, et al.
Publicado: (2023)